AVENUE THERAPEUTICS INC (ATXI)
US05360L3042 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.49M | -3.60M | -3.73M | -5.15M | -25.91M | |||
| Change In Working Capital | -290.00K | 410.00K | -460.00K | -170.00K | -2.19M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 1.33M | -4.40M | 440.00K | 710.00K | 1.84M | |||
| OPERATING CASH FLOW | -9.45M | -7.60M | -3.75M | -4.61M | -26.26M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | -3.00M | N/A | 0.00 | -1.00M | 0.00 | |||
| INVESTING CASH FLOW | -3.00M | N/A | 0.00 | -1.00M | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 7.53M | 11.05M | 5.04M | 0.00 | 35.00M | |||
| Other Financing Activity | N/A | -510.00K | -660.00K | 0.00 | -2.67M | |||
| FINANCING CASH FLOW | 7.53M | 10.54M | 4.38M | 0.00 | 32.33M | |||
| CHANGE IN CASH | -4.93M | 2.95M | 630.00K | -5.61M | 6.07M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.45M | -7.60M | -3.75M | -4.61M | -26.26M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -9.45M | -7.60M | -3.75M | -4.61M | -26.26M | |||
All data in USD